# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 71-80 of 2712 results.
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Status: Completed
Last Changed: Feb 19, 2016
First Received: Sep 22, 2005
Disease(s): Ovarian Cancer
Intervention(s): Imatinib Mesylate, Docetaxel
Locations: Medical & Surgical Specialists, LLC, Galesburg, Illinois, United States
Elkhart Clinic, Elkhart, Indiana, United States
Oncology Hematology Associates of SW Indiana, Evansville, Indiana, United States
Fort Wayne Oncology & Hematology, Inc, Fort Wayne, Indiana, United States
Indiana University Cancer Center, Indianapolis, Indiana, United States
... and 5 other locations.
Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction
Status: Completed
Last Changed: Mar 30, 2016
First Received: Sep 23, 2008
Disease(s): Ovarian Cancer
Intervention(s): Fourier transform ion cyclotron resonance mass spectrometry, chromatography, diagnostic laboratory biomarker analysis, questionnaire administration
Locations: Pine Street Foundation, San Anselmo, California, United States
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
California Pacific Medical Center - California Campus, San Francisco, California, United States
University of Maine, Orono, Maine, United States
Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer
Status: Active, not recruiting
Last Changed: Aug 20, 2020
First Received: Sep 07, 2016
Disease(s): Recurrent Platinum Resistant Ovarian Cancer
Intervention(s): cediranib and olaparib
Locations: Research Site, Mobile, Alabama, United States
Research Site, Anchorage, Alaska, United States
Research Site, Downey, California, United States
Research Site, Greenbrae, California, United States
Research Site, Los Angeles, California, United States
... and 21 other locations.
Trial Comparing Niraparib-bevacizumab-TSR042 and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer
Status: Not yet recruiting
Last Changed: Jan 17, 2019
First Received: Jan 16, 2019
Disease(s): Ovarian Cancer
Intervention(s): Niraparib, Bevacizumab, TSR042, Carboplatin, Paclitaxel
Locations: NSGO, Copenhagen, Sjaelland, Denmark
Rigshospitalet, Copenhagen, Sjaelland, Denmark
Rigshospitalet, København Ø, Sjaelland, Denmark
Aalborg University Hospital, Aalborg, Denmark
Tampere University Hospital, Tampere, Finland
... and 4 other locations.
Role of Surgery in Advanced Ovarian Cancer
Status: Completed
Last Changed: Jun 10, 2019
First Received: Jun 10, 2019
Disease(s): Ovarian Cancer
Locations: Institut Claudius Regaud - IUCT-Oncopole, Toulouse, Occitanie, France
A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer
Status: Withdrawn
Last Changed: Oct 18, 2019
First Received: Sep 13, 2017
Disease(s): Ovarian Cancer
Intervention(s): VAL-083, Dianhydrogalactitol
Locations: St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
Henry Ford Hospital, Detroit, Michigan, United States
Sarah Cannon Research Institute, Nashville, Tennessee, United States
Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy
Status: Recruiting
Last Changed: Dec 05, 2019
First Received: Nov 14, 2019
Disease(s): Ovarian Cancer
Intervention(s): W_ova1 Vaccine
Locations: UMCG, Groningen, Netherlands
Ovarian Cancer Patient-Centered Decision Aid
Status: Completed
Last Changed: Jun 10, 2019
First Received: Oct 08, 2014
Disease(s): Stage III Ovarian Cancer
Intervention(s): Decision Aid
Locations: University of California, Irvine, California, United States
Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
Status: Suspended
Last Changed: May 16, 2019
First Received: Oct 11, 2010
Disease(s): Ovarian Cancer
Intervention(s): ovarian cancer surgery
Locations: Clinique Sainte Thérèse, Amiens, France
Centre Paul Papin, Angers, France
Hospital, Angers, France
Hospital, Brest, France
Centre Jean Perrin, Clermont-Ferrand, France
... and 15 other locations.
Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) to Treat Platinum-sensitive Ovarian Cancer
Status: Completed
Last Changed: Jul 17, 2014
First Received: Oct 29, 2009
Disease(s): Epithelial Ovarian Cancer
Intervention(s): Farletuzumab, Carboplatin, and PLD
Locations: University of Alabama at Birmingham Medical Center, Birmingham, Alabama, United States
Johns Hopkins University, Baltimore, Maryland, United States
Schwartz Gynecologic Oncology, Brightwaters, New York, United States
Chattanooga GYN Oncology, Chattanooga, Tennessee, United States
International Beneficence Clinical Research, LLC, Harlingen, Texas, United States
... and 1 other locations.